Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Environmental Toxicology and Chemistry|January 10, 2006
A field assessment of long-term laboratory sediment toxicity tests with the amphipod Hyalella aztecaChristopher G Ingersoll, Ning Wang, Jeannie M R Hayward, et al.
The Lancet. Haematology|November 10, 2022
Second primary malignancies in patients with haematological cancers treated with lenalidomide: a systematic review and meta-analysisKainat Saleem, Joseph Franz, Mary Lou Klem, et al.
Ecological Applications : a Publication of the Ecological Society of America|April 4, 2017
Lake nutrient stoichiometry is less predictable than nutrient concentrations at regional and sub-continental scalesSarah M Collins, Samantha K Oliver, Jean-Francois Lapierre, et al.
Global Change Biology|August 24, 2017
Unexpected stasis in a changing world: Lake nutrient and chlorophyll trends since 1990Samantha K Oliver, Sarah M Collins, Patricia A Soranno, et al.
The Science of the Total Environment|February 23, 2020
Terrestrial loads of dissolved organic matter drive inter-annual carbon flux in subtropical lakes during times of droughtChih-Yu Chiu, John R Jones, James A Rusak, et al.
Blood|August 23, 2017
Neutral tumor evolution in myeloma is associated with poor prognosisDavid C Johnson, Oleg Lenive, Jonathan Mitchell, et al.
British Journal of Haematology|December 21, 2022
The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from 'Myeloma XI', a multicentre, open-label, randomised, phase III trialMatthew W Jenner, Charlotte Pawlyn, Faith E Davies, et al.
Eclinicalmedicine|August 9, 2023
Maintenance lenalidomide in newly diagnosed transplant eligible and non-eligible myeloma patients; profiling second primary malignancies in 4358 patients treated in the Myeloma XI TrialJohn R Jones, David A Cairns, Tom Menzies, et al.
Cancers|January 11, 2025
A Novel In Vitro Model of the Bone Marrow Microenvironment in Acute Myeloid Leukemia Identifies CD44 and Focal Adhesion Kinase as Therapeutic Targets to Reverse Cell Adhesion-Mediated Drug ResistanceEleni E Ladikou, Kim Sharp, Fabio A Simoes, et al.
Blood|May 22, 2020
Thrombosis in patients with myeloma treated in the Myeloma IX and Myeloma XI phase 3 randomized controlled trialsCharlotte A Bradbury, Zoe Craig, Gordon Cook, et al.
Pageof 5